Factors influencing clinicians' decisions to prescribe medication to prevent coronary heart disease

被引:10
|
作者
Greenfield, S
Bryan, S
Gill, P
Gutridge, K
Marshall, T
机构
[1] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2TT, W Midlands, England
[3] Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England
关键词
clinicians; coronary heart disease; preventive prescribing;
D O I
10.1111/j.1365-2710.2004.00615.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and objective: There are variations between individual clinicians as to the thresholds at which preventive treatment for coronary heart disease (CHD) should commence. Patients' decisions may be influenced by clinicians' recommendations. Free text comments added by respondents to closed questionnaires may identify areas which are of real concern to them about the topic being studied. The study aimed to identify issues voluntarily raised by clinicians surrounding the decision to prescribe preventive treatment for CHD. Methods: An analysis was undertaken of the free text comments made by cardiologists, general practitioners and practice nurses who responded to a closed question postal questionnaire in which they were asked to identify at which level of pretreatment risk they would offer treatment. Results and discussion: A similar percentage of respondents in each professional group provided free text comments. Clinicians' concerns centred on five main themes around prescribing decisions: the risks and benefits of treatment, the patient's role in treatment decisions, patient characteristics, costs to patients, and costs to the health services. Different issues may be of more concern to some professional groups than others. Conclusion: In addition to the use of risk assessment tools and guidelines, clinicians' actual prescribing behaviour may be influenced by more subjective factors. Patients at similar risk may receive different advice depending on the individual clinician they consult.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 50 条
  • [1] MEDICATION TO PREVENT CORONARY HEART-DISEASE
    METELITSA, VI
    [J]. KARDIOLOGIYA, 1987, 27 (01) : 5 - 10
  • [2] Clinicians' preferences for treatments to prevent coronary heart disease: a postal survey
    Bryan, S
    Gill, P
    Greenfield, S
    Gutridge, K
    Marshall, T
    [J]. HEART, 2005, 91 (03) : 377 - 378
  • [3] Patient Perspectives on Factors Influencing Medication Adherence Among People with Coronary Heart Disease (CHD) and CHD Risk Factors
    Mondesir, Favel L.
    Levitan, Emily B.
    Malla, Gargya
    Mukerji, Reshmi
    Carson, April P.
    Safford, Monika M.
    Turan, Janet M.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 2017 - 2027
  • [4] Should physicians prescribe alcohol to prevent coronary artery disease?
    Ellison, RC
    [J]. CORONARY ARTERY DISEASE: PREVENTION TO INTERVENTION, 2000, : 37 - 42
  • [5] Clinicians' views on factors influencing prescribing decisions for patients with dementia
    Lee, P. R.
    Boyd, C.
    Green, A.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S294 - S294
  • [6] Psychosocial factors influencing development and course of coronary heart disease
    Siegrist, J
    [J]. HERZ, 2001, 26 (05) : 316 - 325
  • [7] Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
    Nordestgaard, Borge G.
    Chapman, M. John
    Humphries, Steve E.
    Ginsberg, Henry N.
    Masana, Luis
    Descamps, Olivier S.
    Wiklund, Olov
    Hegele, Robert A.
    Raal, Frederick J.
    Defesche, Joep C.
    Wiegman, Albert
    Santos, Raul D.
    Watts, Gerald F.
    Parhofer, Klaus G.
    Hovingh, G. Kees
    Kovanen, Petri T.
    Boileau, Catherine
    Averna, Maurizio
    Boren, Jan
    Bruckert, Eric
    Catapano, Alberico L.
    Kuivenhoven, Jan Albert
    Pajukanta, Paeivi
    Ray, Kausik
    Stalenhoef, Anton F. H.
    Stroes, Erik
    Taskinen, Marja-Riitta
    Tybjaerg-Hansen, Anne
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (45) : 3478 - +
  • [8] Factors Influencing the Diferent Incidences between Coronary Heart Disease and Stroke
    杜福昌
    王海燕
    朱杰
    张仕清
    钱卫冲
    王震震
    王敬良
    [J]. The Journal of Biomedical Research, 1999, (01) : 2 - 6
  • [9] Should we prescribe antioxidants to patients with coronary heart disease?
    Rapola, JM
    [J]. EUROPEAN HEART JOURNAL, 1998, 19 (04) : 530 - 532
  • [10] HARD DECISIONS: EXTRA-THERAPEUTIC FACTORS AND RESIDENT WILLINGNESS TO PRESCRIBE MEDICATION FOR ERECTILE DYSFUNCTION
    Farber, Neil
    Cederquist, Lynette
    Devereaux, Mary
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 288 - 289